tlooto
Sign up
SCIESCOPUSQ3

JOURNAL OF EMERGENCY MEDICINE

ELSEVIER SCIENCE INC, United States

JOURNAL OF EMERGENCY MEDICINE is an academic journal published by ELSEVIER SCIENCE INC (United States). Identifiers: ISSN 0736-4679, eISSN 1090-1280. Indexed in SCIE, SCOPUS. Metrics: JIF 1.3, CiteScore 2.3, SJR 0.470, SNIP 0.69. Subject areas: EMERGENCY MEDICINE. tlooto lists 4,590 papers from this journal.

CiteScore

2.30

Scopus citation metric

SJR

0.470

SCImago rank

SNIP

0.69

Source normalized impact

Percentage rank

-

JIF percentile rank

Journal profile

ISSN
0736-4679
eISSN
1090-1280
Abbreviation
J EMERG MED
Publisher
ELSEVIER SCIENCE INC
Country
United States

Web of Science categories

SCIEEMERGENCY MEDICINE

Scopus ASJC categories

2711 Emergency Medicine

Keywords

Emergency Medicine

Papers in this journal

Recent papers

  1. Peak Expiratory flow Rate for Emergency Department Management of Acute Asthma Exacerbation: A Randomized Controlled Trial Pilot Study.

    2026

  2. Syncope, ST-Elevation Myocardial Infarction (STEMI), or Trauma? Blunt Coronary Bypass Graft Rupture in the Emergency Department.

    2026

  3. Landmark vs. Ultrasound-Guided Identification of the Cricothyroid Membrane: A Randomized, Prospective Trial

    2026

  4. Male with a Thumb Out of Joint

    2026

  5. Response to: "Letter to the Editor Regarding Cervical Spine Clearance in Adult and Pediatric Trauma: a Systematic Review"

    2026

Most cited papers

  1. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct

    2018 · 2,504 citations

  2. Effect of Treatment Delay, Age, and Stroke Severity on the Effects of Intravenous Thrombolysis with Alteplase for Acute Ischaemic Stroke: A Meta-analysis of Individual Patient Data from Randomized Trials

    2015 · 2,083 citations

  3. Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase

    1988 · 1,153 citations

  4. Environmental and occupational medicine

    1983 · 738 citations

  5. Idarucizumab for Dabigatran Reversal Full Cohort Analysis

    2017 · 489 citations